Adherium (ASX:ADRDA) Land And Improvements : A$0.00 Mil (As of Jun. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Adherium Land And Improvements?

Adherium's land and improvements for the quarter that ended in Jun. 2024 was A$0.00 Mil.

Adherium Land And Improvements Historical Data

The historical data trend for Adherium's Land And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adherium Land And Improvements Chart

Adherium Annual Data

Trend

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Land And Improvements

Get a 7-Day Free Trial

Adherium Semi-Annual Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Land And Improvements	Get a 7-Day Free Trial											-	-	-	-	-

Adherium Land And Improvements Calculation

Land is the surface or crust of the earth, which can be used to support structures, and may be used to grow crops, grass, shrubs, and trees. Land is characterized as having an unlimited life (indefinite). Land improvement is a long-term asset which indicates the cost of the constructed improvements to land, such as driveways, walkways, lighting, and parking lots.

Adherium Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Adherium Ltd (ASX:ADRDA) » Definitions » Land And Improvements

Comparable Companies

Traded in Other Exchanges

N/A

Address

333 Collins Street, Level 14, Melbourne, VIC, AUS, 3000

Website

https://www.adherium.com

Adherium Ltd is engaged in the development, manufacture, and supply of its Hailie digital health technologies that address sub-optimal medication use and improve health outcomes in chronic disease. Geographically, it derives a majority of its revenue from Europe and also has a presence in New Zealand and Australia; North America, and Asia.

Adherium Headlines

No Headlines